BrightSpire Capital, Inc. (BRSP) stock: key figures, P/E, revenue and dividend
Real Estate · United States · ISIN US10949T1097
BrightSpire Capital, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 330.59 m USD |
| EBIT | -28.94 m USD |
| Net income | -31.15 m USD |
| Diluted EPS – continuing operations | -0.26 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BrightSpire Capital, Inc.
BrightSpire Capital, Inc. operates as a commercial real estate (CRE) credit real estate investment trust in the United States and Norway. It operates through Senior and Mezzanine Loans and Preferred Equity; Net Leased and Other Real Estate; and Corporate and Other segments. The company focuses on originating, acquiring, financing, and managing a diversified portfolio of CRE debt investments consisting of senior mortgage loans, mezzanine loans, preferred equity investments, net leased real estate and other real estate properties, and CRE debt securities. It also engages in money market activities; and invests in private equity funds. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Colony Credit Real Estate, Inc. and changed its name to BrightSpire Capital, Inc. in June 2021. BrightSpire Capital, Inc. was incorporated in 2017 and is based in New York, New York.
More stocks
- Ronshin Group A (301231.SZ)
- Korea SPAC 3 (222080.KQ)
- Chang Lan Electric Technology Co Ltd (002879.SZ)
- Seers Technology (458870.KQ)
- Citra Putra Realty Tbk PT (CLAY.JK)
- Cham Swiss Properties AG (CHAM.SW)
- Changzhou Evergreen Technology Co. Ltd. A (001324.SZ)
- Onconic Therapeutics Inc. (476060.KQ)
- IQE PLC (IQE.L)
- Jiangsu Apon Medical Technology Co Ltd Class A (300753.SZ)
- Xinjiang Chalkis Co Ltd (000972.SZ)
- First Bancorp, Inc /ME/ (FNLC)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.